Christine Marie Anterasian, MD

Dr. Anterasian’s research is focused on tuberculosis and understanding the innate immune response to infection. She is interested in identifying novel pathways in host defense against M. tuberculosis that can inform the development of host-directed therapeutics. Additionally, Dr. Anterasian studies infant immunogenetic regulation of BCG vaccine responses and susceptibility to pediatric tuberculosis. Dr. Anterasian research combines systems biology, genetics, and immunoassays approaches to advance our understanding of the host immune response to tuberculosis. 
Dr. Anterasian also attends on the inpatient Infectious Diseases service at Seattle Children’s Hospital. She has a clinical interest in infections in patients with inborn errors of immunity and is completing a second fellowship in Allergy/Immunology.